| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJMOA0900428 |
| P698 | PubMed publication ID | 19710484 |
| P50 | author | Raphael Twerenbold | Q30537260 |
| Roland Bingisser | Q43190852 | ||
| P2093 | author name string | Christian Mueller | |
| Tobias Reichlin | |||
| Willibald Hochholzer | |||
| Markus Noveanu | |||
| Mihael Potocki | |||
| Tobias Breidthardt | |||
| Claudia Stelzig | |||
| Stefano Bassetti | |||
| Katrin Winkler | |||
| Stephan Steuer | |||
| Nora Schaub | |||
| Sabine Hartwiger | |||
| Christine Buerge | |||
| Stefan Biedert | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| diagnosis | Q16644043 | ||
| P1104 | number of pages | 10 | |
| P304 | page(s) | 858-867 | |
| P577 | publication date | 2009-08-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Early diagnosis of myocardial infarction with sensitive cardiac troponin assays | |
| P478 | volume | 361 |
| Q36211940 | "Real life use" of troponin in the emergency department: a survey of over 3000 cases |
| Q38178539 | "Troponin elevation in coronary ischemia and necrosis". |
| Q47620332 | 0/1-Hour Triage Algorithm for Myocardial Infarction in Patients With Renal Dysfunction |
| Q22241922 | 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines |
| Q53796787 | 2014 PHA Clinical Practice Guidelines for the Diagnosis and Management of Patients with Coronary Heart Disease. |
| Q42134079 | 3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology. |
| Q38788267 | A 0-Hour/1-Hour Protocol for Safe, Early Discharge of Chest Pain Patients. |
| Q42571636 | A High-Performance Fluorescence Immunoassay Based on the Relaxation of Quenching, Exemplified by Detection of Cardiac Troponin I. |
| Q64996904 | A Low Early High-density Lipoprotein Cholesterol Level Is an Independent Predictor of In-hospital Death in Patients with Acute Coronary Syndrome. |
| Q36515746 | A Synergistic Role of Myeloperoxidase and High Sensitivity Troponin T in the Early Diagnosis of Acute Coronary Syndrome |
| Q93086040 | A comprehensive validation of very early rule-out strategies for non-ST-segment elevation myocardial infarction in emergency departments: protocol for a multicentre prospective cohort study |
| Q46059674 | A multicentre analysis of troponin use in clinical practice |
| Q48510946 | A novel troponin I rule-out value below the upper reference limit for acute myocardial infarction |
| Q55452820 | A practical approach for the validation and clinical implementation of a high-sensitivity cardiac troponin I assay across a North American city. |
| Q37961568 | A review of causes and systemic approach to cardiac troponin elevation |
| Q38751990 | A synergistic role of ischemia modified albumin and high-sensitivity troponin T in the early diagnosis of acute coronary syndrome |
| Q37765287 | A timely diagnosis of myocardial infarction. |
| Q41083032 | ANMCO-SIMEU Consensus Document: in-hospital management of patients presenting with chest pain |
| Q92308458 | Ablation of the calpain-targeted site in cardiac myosin binding protein-C is cardioprotective during ischemia-reperfusion injury |
| Q51586325 | Acute MI: triple-markers resurrected or Bayesian dice? |
| Q26746199 | Acute chest pain in the high-sensitivity cardiac troponin era: A changing role for noninvasive imaging? |
| Q88960063 | Acute coronary syndromes |
| Q84947003 | Acute coronary syndromes: Troponin triumphant? |
| Q36265313 | Acute kidney injury induces high-sensitivity troponin measurement changes after cardiac surgery |
| Q35337806 | Addition of heart score to high-sensitivity troponin T versus conventional troponin T in risk stratification of patients with chest pain at the coronary emergency rooms |
| Q37700011 | Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. |
| Q45374847 | Age-sex distribution of patients with high-sensitivity troponin T levels below the 99th percentile |
| Q44769587 | Age-specific 99th percentile cutoff of high-sensitivity cardiac troponin T for early prediction of non-ST-segment elevation myocardial infarction (NSTEMI) in middle-aged patients. |
| Q37066826 | Almanac 2011: Acute Coronary Syndromes. The National Society Journals Present Selected Research that has Driven Recent Advances in Clinical Cardiology |
| Q27014824 | An historical approach to the diagnostic biomarkers of acute coronary syndrome |
| Q85167019 | Analytical characteristics of the Roche highly sensitive troponin T assay and its application to a cardio-healthy population |
| Q27692060 | Angiogenic factors in diagnosis, management, and research in preeclampsia |
| Q38542462 | Anthracycline-Induced Cardiomyopathy in Adults |
| Q38876279 | Appropriate pathology ordering? Troponin testing within an Australian Emergency Department. |
| Q102379332 | Artificial intelligence algorithm for detecting myocardial infarction using six-lead electrocardiography |
| Q33555770 | Asia-Pacific consensus statement on the optimal use of high-sensitivity troponin assays in acute coronary syndromes diagnosis: focus on hs-TnI. |
| Q38950900 | Assessing Cardiovascular Risk and Testing in Type 2 Diabetes |
| Q50905583 | Assessing electronic health record systems in emergency departments: Using a decision analytic Bayesian model. |
| Q44243789 | Assessment of microRNAs in patients with unstable angina pectoris |
| Q41641157 | Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study |
| Q40823003 | Association between high-sensitivity troponin T, left ventricular hypertrophy, and myocardial performance index |
| Q86836389 | Association of high-sensitivity assayed troponin I with cardiovascular phenotypes in the general population: the population-based Gutenberg health study |
| Q43241353 | Association of troponin T and altered lipid profile in patients admitted with acute myocardial infarction |
| Q41666469 | Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population |
| Q88786608 | Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017 |
| Q51503137 | Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction. |
| Q36438919 | Autoantibodies to apolipoprotein A-1 in cardiovascular diseases: current perspectives |
| Q38571881 | B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review. |
| Q33967122 | BNP but Not s-cTnln is associated with cardioembolic aetiology and predicts short and long term prognosis after cerebrovascular events |
| Q34658167 | Basal and ischemia-induced transcardiac troponin release into the coronary circulation in patients with suspected coronary artery disease |
| Q49675698 | Baseline type 2 diabetes had a significant association with elevated high sensitivity cardiac troponin T levels in Chinese community-dwelling population: a 5-year prospective analysis |
| Q38353580 | Beyond cardiac troponin: recent advances in the development of alternative biomarkers for cardiovascular disease |
| Q39204219 | Biobanks for cardiovascular epidemiology and prevention |
| Q35185085 | Biomarkers after risk stratification in acute chest pain (from the BRIC Study). |
| Q38172885 | Biomarkers and acute coronary syndromes: an update |
| Q38059154 | Biomarkers in acute coronary artery disease |
| Q38006640 | Biomarkers in acute heart failure--state of the art. |
| Q37994306 | Biomarkers in acute myocardial injury |
| Q83575959 | Biomarkers in aggregate |
| Q47703138 | Biomarkers in cancer therapy related cardiac dysfunction (CTRCD). |
| Q27005967 | Biomarkers of acute myocardial infarction in the elderly: troponin and beyond |
| Q50538363 | Blood cells characteristics as determinants of acute myocardial infarction. |
| Q38581423 | Cardiac CT angiography for evaluation of acute chest pain |
| Q88008386 | Cardiac CT in the Emergency Department: Contrasting Evidence from Registries and Randomized Controlled Trials |
| Q98184293 | Cardiac biomarkers in patients with prostate cancer and cardiovascular disease receiving gonadotrophin releasing hormone agonist vs antagonist |
| Q35856435 | Cardiac biomarkers in the intensive care unit |
| Q37670587 | Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin |
| Q38357689 | Cardiac computed tomography in patients with acute chest pain |
| Q35634229 | Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. |
| Q42139860 | Cardiac myosin binding protein-C: a potential early-stage, cardiac-specific biomarker of ischemia-reperfusion injury |
| Q35252781 | Cardiac myosin-binding protein C: a potential early biomarker of myocardial injury. |
| Q34333247 | Cardiac troponin I but not cardiac troponin T adheres to polysulfone dialyser membranes in an in vitro haemodialysis model: explanation for lower serum cTnI concentrations following dialysis |
| Q84597610 | Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy |
| Q53155249 | Cardiac troponin T determination by a highly sensitive assay in postmortem serum and pericardial fluid. |
| Q38131688 | Cardiac troponin level elevations not related to acute coronary syndromes |
| Q38062864 | Cardiac troponins I and T: molecular markers for early diagnosis, prognosis, and accurate triaging of patients with acute myocardial infarction |
| Q34150309 | Cardiomyocyte injury assessed by a highly sensitive troponin assay and sudden cardiac death in the community: the Cardiovascular Health Study |
| Q38242641 | Cardiomyopathy associated with cancer therapy |
| Q58919589 | Cardiovascular Biomarkers in ACS: State of the Art 2012 |
| Q64289339 | Challenges in high-sensitive troponin assay interpretation for intensive therapy |
| Q36129159 | Chemiluminometric Immunosensor for High-Sensitivity Cardiac Troponin I Employing a Polymerized Enzyme Conjugate as a Tracer |
| Q26771814 | Chest pain and high-sensitivity troponin: What is the evidence? |
| Q37788377 | Chest pain of cardiac and noncardiac origin |
| Q37705432 | Choline in acute coronary syndrome: an emerging biomarker with implications for the integrated assessment of plaque vulnerability |
| Q37572416 | Circulating MicroRNA-145 is Associated with Acute Myocardial Infarction and Heart Failure |
| Q88427412 | Circulating Troponin I Level in Patients with Acute Ischemic Stroke |
| Q37765289 | Clinical application of sensitive cardiac troponin assays: potential and limitations |
| Q33706806 | Clinical criteria replenish high-sensitive troponin and inflammatory markers in the stratification of patients with suspected acute coronary syndrome |
| Q39910240 | Clinical impact of a high-sensitivity troponin assay introduction on patients presenting to the emergency department |
| Q50672369 | Clinical impact of the 2010-2012 low-end shift of high-sensitivity cardiac troponin T. |
| Q92468384 | Clinical impact of using a more sensitive troponin assay in patients with acute chest pain |
| Q35031757 | Clinical implications of high-sensitivity cardiac troponin measurements in hospitalized medical patients |
| Q85090778 | Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain — An evaluation with respect to the Universal Definition of Myocardial Infarction |
| Q64986825 | Clinical role of serum Copeptin in acute coronary syndrome. |
| Q37486443 | Clinical use of ultrasensitive cardiac troponin I assay in intermediate- and high-risk surgery patients. |
| Q92920054 | Close association between circulating high-sensitivity cardiac troponin I and metabolic syndrome in the general population |
| Q59809959 | Combined Use of High-Sensitive Cardiac Troponin, Copeptin, and the Modified HEART Score for Rapid Evaluation of Chest Pain Patients |
| Q39449186 | Comment on "A Unique Case of Cardiac Arrest following K2 Abuse". |
| Q64068499 | Comment on: Increased level of high-sensitivity cardiac troponin T in a geriatric population is determined by comorbidities compared to age |
| Q44325501 | Comparison of contemporary troponin assays with the novel biomarkers, heart fatty acid binding protein and copeptin, for the early confirmation or exclusion of myocardial infarction in patients presenting to the emergency department with chest pain |
| Q51364733 | Comparison of diagnostic accuracy between three different rules of interpreting high sensitivity troponin T results. |
| Q39836182 | Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome |
| Q35569452 | Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction |
| Q38717558 | Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity |
| Q38136336 | Conventional and novel diagnostic biomarkers of acute myocardial infarction: a promising role for circulating microRNAs |
| Q35556651 | Copeptin testing in acute myocardial infarction: ready for routine use? |
| Q91601225 | Copeptin with high-sensitivity troponin at presentation is not inferior to serial troponin measurements for ruling out acute myocardial infarction |
| Q41012001 | Coronary CT angiography in acute chest pain |
| Q38561463 | Coronary artery disease in the military patient. |
| Q35805400 | Correlation of concentrations of high-sensitivity troponin T and high-sensitivity C-reactive protein with plaque progression as measured by CT coronary angiography |
| Q30418270 | Design of surface modifications for nanoscale sensor applications |
| Q86090634 | Determinants and prognostic significance of an intra-dialysis rise of cardiac troponin I measured by sensitive assay in hemodialysis patients |
| Q91253196 | Diagnosing myocardial infarction: a highly sensitive issue |
| Q91554784 | Diagnosis and prognosis of myocardial infarction on a plasmonic chip |
| Q35623487 | Diagnosis of Non-ST-Elevation Acute Coronary Syndrome by the Measurement of Heart-Type Fatty Acid Binding Protein in Serum: A Prospective Case Control Study |
| Q33667779 | Diagnostic accuracy of a new cardiac electrical biomarker for detection of electrocardiogram changes suggestive of acute myocardial ischemic injury |
| Q57101391 | Diagnostic accuracy of adding copeptin to cardiac troponin for non-ST-elevation myocardial infarction: A systematic review and meta-analysis |
| Q37599608 | Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis. |
| Q38237059 | Diagnostic accuracy of sensitive or high-sensitive troponin on presentation for myocardial infarction: a meta-analysis and systematic review |
| Q28085167 | Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis |
| Q40501284 | Diagnostic and Prognostic Utility of Circulating Cytochrome c in Acute Myocardial Infarction. |
| Q84213250 | Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome |
| Q35839487 | Diagnostic and prognostic utility of early measurement with high-sensitivity troponin T assay in patients presenting with chest pain |
| Q58197552 | Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarction |
| Q35557538 | Diagnostic implications of an elevated troponin in the emergency department. |
| Q35085516 | Diagnostic performance of high-sensitivity troponin T, myeloperoxidase, and pregnancy-associated plasma protein A assays for triage of patients with acute myocardial infarction |
| Q47133037 | Diagnostic performance of point-of-care and central laboratory cardiac troponin assays in an emergency department |
| Q37291924 | Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity cardiac troponin T in an unselected emergency department population |
| Q41599733 | Diagnostic value of left bundle branch block in patients with acute myocardial infarction. A prospective analysis |
| Q52687502 | Diagnostic value of the cardiac electrical biomarker, a novel ECG marker indicating myocardial injury, in patients with symptoms suggestive of non-ST-elevation myocardial infarction. |
| Q43956069 | Diastolic dysfunction and high levels of new cardiac biomarkers as risk factors for cardiovascular events and mortality in hemodialysis patients |
| Q35664621 | Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study |
| Q47275584 | Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction. |
| Q50280119 | Discharge Communication in Patients Presenting to the Emergency Department With Chest Pain: Defining the Ideal Content. |
| Q64985481 | Do MicroRNAs Modulate Visceral Pain? |
| Q62072512 | Does a lower diagnostic threshold of sensitive plasma troponin I assay improve clinical outcomes of patients with chest pain? |
| Q36389315 | Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs |
| Q50217429 | Early diagnosis of acute myocardial infarction in patients with mild elevations of cardiac troponin. |
| Q53081382 | Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. |
| Q50536931 | Early diagnosis of postpartum acute myocardial infarction with combined use of troponin T and heart-type fatty acid-binding protein rapid assay. |
| Q34676067 | Early diagnosis of rats with acute myocardial infarction by measurement of brain natriuretic peptide |
| Q35059506 | Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study |
| Q53151448 | Early release of high-sensitive cardiac troponin during complex catheter ablation for ventricular tachycardia and atrial fibrillation. |
| Q51046961 | Early rule-out of acute coronary syndrome using undetectable levels of high sensitivity troponin T. |
| Q34989909 | Early troponin T and prediction of potentially correctable in-hospital complications after coronary artery bypass grafting surgery |
| Q37276851 | Effectiveness of practices for improving the diagnostic accuracy of Non ST Elevation Myocardial Infarction in the Emergency Department: A Laboratory Medicine Best Practices™ systematic review |
| Q41997691 | Elevated copeptin is associated with atherosclerosis and diabetic kidney disease in adults with type 1 diabetes |
| Q36476201 | Elevated high-sensitive troponin T on admission is an indicator of poor long-term outcome in patients with subarachnoid haemorrhage: a prospective observational study |
| Q35399464 | Elevated troponin T after acute ischemic stroke: Association with severity and location of infarction |
| Q33923186 | Emergency Cardiac Biomarkers and Point-of-Care Testing: Optimizing Acute Coronary Syndrome Care Using Small-World Networks In Rural Settings |
| Q33744203 | Emergency department and office-based evaluation of patients with chest pain |
| Q30234679 | Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease |
| Q47166618 | Encapsulation-Stabilized, Europium Containing Nanoparticle as a Probe for Time-Resolved luminescence Detection of Cardiac Troponin I. |
| Q96303042 | Enhancement of label-free biosensing of cardiac troponin I |
| Q41012723 | Ethnic differences in clinical outcome of patients presenting to the emergency department with chest pain |
| Q45787251 | Evaluating new diagnostic and prognostic biomarkers in cardiovascular disease |
| Q43844364 | Evaluation and outcomes of patients admitted to a tertiary medical assessment unit with acute chest pain of possible coronary origin. |
| Q61449640 | Evaluation of a high-sensitivity cardiac troponin I assay compared to a first-generation cardiac troponin I assay in Doberman Pinschers with and without dilated cardiomyopathy |
| Q36900402 | Evaluation of cardiac troponin I in dogs presenting to the emergency room using a point-of-care assay |
| Q51837358 | Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study. |
| Q37155324 | Evidence and Cost Effectiveness Requirements for Recommending New Biomarkers |
| Q36428071 | Experimental and theoretical investigation of the precise transduction mechanism in giant magnetoresistive biosensors |
| Q30401812 | Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging |
| Q40070422 | External Validation of the Manchester Acute Coronary Syndromes Decision Rule |
| Q35184977 | Factors affecting high-sensitivity cardiac troponin T elevation in Japanese metabolic syndrome patients |
| Q42350846 | Falsely elevated troponin: rare occurrence or future problem |
| Q53577866 | Fast assessment and management of chest pain patients without ST-elevation in the pre-hospital gateway (FamouS Triage): ruling out a myocardial infarction at home with the modified HEART score. |
| Q44163203 | Fast assessment and management of chest pain without ST-elevation in the pre-hospital gateway: rationale and design |
| Q35738634 | Frequency and Effects of Excess Dosing of Anticoagulants in Patients ≤55 Years With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention (from the VIRGO Study). |
| Q42735978 | From lactate to soluble urokinase plasminogen activator receptor: The journey for ideal cardiac biomarker: Are we there in 2016? |
| Q39895236 | From multimarker approach to multiplex assays in acute coronary syndromes: what are we searching for? |
| Q37115239 | GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study. |
| Q50733875 | Gender-specific diagnostic performance of a new high-sensitivity cardiac troponin I assay for detection of acute myocardial infarction. |
| Q38390243 | Gender-specific uncertainties in the diagnosis of acute coronary syndrome. |
| Q34330829 | Glycogen phosphorylase isoenzyme BB in the diagnosis of acute myocardial infarction: a meta-analysis |
| Q38865373 | HEART score performance in Asian and Caucasian patients presenting to the emergency department with suspected acute coronary syndrome |
| Q38100647 | Heart failure biomarkers |
| Q54978892 | Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis. |
| Q38247939 | Heart-type fatty acid binding protein in early diagnosis of myocardial infarction in the era of high-sensitivity troponin: a systematic review and meta-analysis |
| Q50923360 | Heart-type fatty acid binding protein is a sensitive biomarker for early AMI detection in troponin negative patients: a pilot study. |
| Q39337183 | High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort |
| Q44131690 | High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation |
| Q28651794 | High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study |
| Q84538472 | High sensitivity troponin in chest pain and acute coronary syndromes. A step forward? |
| Q98386250 | High sensitivity troponin measurement in critical care: Flattering to deceive or 'never means nothing'? |
| Q85212685 | High sensitivity troponins and better patient care |
| Q47772072 | High sensitivity troponins in contemporary cardiology practice: are we turning a corner? |
| Q48353689 | High-Sensitive Troponin T and N-Terminal Pro B-Type Natriuretic Peptide for Early Detection of Stress-Induced Cardiomyopathy in Patients with Subarachnoid Hemorrhage |
| Q38657042 | High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants |
| Q35994634 | High-Sensitivity Cardiac Troponin Concentrations in Patients with Chest Discomfort: Is It the Heart or the Kidneys As Well? |
| Q47782446 | High-Sensitivity Cardiac Troponin I as a Gatekeeper for Coronary Computed Tomography Angiography and Stress Testing in Patients with Acute Chest Pain |
| Q38608703 | High-Sensitivity Cardiac Troponin for the Diagnosis of Patients with Acute Coronary Syndromes |
| Q36970693 | High-contrast grating resonators for label-free detection of disease biomarkers |
| Q36769832 | High-sensitive cardiac troponin T |
| Q33786119 | High-sensitive troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation |
| Q37977873 | High-sensitive troponin T measurements: what do we gain and what are the challenges? |
| Q39223912 | High-sensitivity assays for troponin in patients with cardiac disease |
| Q36974321 | High-sensitivity cardiac troponin T compared with standard troponin T testing on emergency department admission: how much does it add in everyday clinical practice? |
| Q45203711 | High-sensitivity cardiac troponin T levels in newly diagnosed hypertensive patients with different left ventricle geometry |
| Q28730261 | High-sensitivity cardiac troponin T: risk stratification tool in patients with symptoms of chest discomfort |
| Q39272975 | High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification |
| Q37722773 | High-sensitivity cardiac troponins in everyday clinical practice |
| Q38131528 | High-sensitivity cardiac troponins: no more 'negatives'. |
| Q34718054 | High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study |
| Q55304633 | High-sensitivity troponin T and copeptin in non-ST acute coronary syndromes: implications for prognosis and role of hsTnT and copeptin in non-STEACS. |
| Q91657682 | High-sensitivity troponin T and long-term adverse cardiac events among patients presenting with suspected acute coronary syndrome in Singapore |
| Q33821446 | High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography |
| Q51373261 | High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study. |
| Q50972435 | High-sensitivity troponin and novel biomarkers for the early diagnosis of non-ST-segment elevation myocardial infarction in patients with atrial fibrillation. |
| Q45983462 | High-sensitivity troponin as an outcome predictor in acute medical admissions. |
| Q42928188 | High-sensitivity troponin assays and the early rule-out of acute myocardial infarction |
| Q37926596 | High-sensitivity troponin assays in the evaluation of patients with acute chest pain in the emergency department |
| Q27007551 | High-sensitivity troponin assays: evidence, indications, and reasonable use |
| Q58737942 | High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial |
| Q44920419 | High-sensitivity troponin: elevated without infarction, is the horse out of the barn? |
| Q35558342 | High-sensitivity versus conventional troponin in the emergency department for the diagnosis of acute myocardial infarction |
| Q53178956 | Highlights from the II International Symposium of Thrombosis and Anticoagulation (ISTA), October 22-23, 2009, São Paulo, Brazil. |
| Q37464638 | Highly Sensitive Detection of Minimal Cardiac Ischemia using Positron Emission Tomography Imaging of Activated Platelets |
| Q48149378 | Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism |
| Q38722294 | Highly sensitive troponin and coronary computed tomography angiography in the evaluation of suspected acute coronary syndrome in the emergency department |
| Q35043956 | Histamine blood concentration in ischemic heart disease patients |
| Q37444674 | Homocysteine is associated with plasma high-sensitivity cardiac troponin T levels in a community-dwelling population |
| Q45044302 | Hot Off the Press: The Use of Very Low Concentrations of High-sensitivity Troponin T to Rule Out Acute Myocardial Infarction Using a Single Blood Test |
| Q58314226 | How to use high-sensitivity cardiac troponins in acute cardiac care |
| Q26825137 | Human cardiac troponin complex. Structure and functions |
| Q35712254 | ICD Shock, Not Ventricular Fibrillation, Causes Elevation of High Sensitive Troponin T after Defibrillation Threshold Testing--The Prospective, Randomized, Multicentre TropShock-Trial |
| Q35714803 | Identification of acute myocardial infarction in patients with atrial fibrillation and chest pain with a contemporary sensitive troponin I assay |
| Q46959632 | Identification of biomarkers for unstable angina by plasma metabolomic profiling |
| Q36601679 | Identification of myocardial injury in the emergency setting |
| Q36589109 | Identifying patients for early discharge: performance of decision rules among patients with acute chest pain |
| Q36338381 | Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS). |
| Q44828860 | Impact of high-sensitivity Troponin T on hospital admission, resources utilization, and outcomes. |
| Q37525860 | Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction. |
| Q54628037 | Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction. |
| Q93001069 | Implementation of High-Sensitivity Cardiac Troponin: Challenges From the International Experience |
| Q44568286 | Incidence and timing of serious arrhythmias after early revascularization in non ST-elevation myocardial infarction |
| Q36142357 | Increased Brain-Specific MiR-9 and MiR-124 in the Serum Exosomes of Acute Ischemic Stroke Patients |
| Q37050331 | Incremental value of objective cardiac testing in addition to physician impression and serial contemporary troponin measurements in women |
| Q35071384 | Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease. |
| Q92824446 | Is high-sensitivity troponin, alone or in combination with copeptin, sensitive enough for ruling out NSTEMI in very early presenters at admission? A post hoc analysis performed in emergency departments |
| Q37810261 | Ischemia modified albumin changes - review and clinical implications |
| Q40353527 | Kinetics of Highly Sensitive Troponin T after Cardiac Surgery |
| Q55059820 | Kinetics of high-sensitivity cardiac troponin T and I differ in patients with ST-segment elevation myocardial infarction treated by primary coronary intervention. |
| Q39392300 | Label-free detection of cardiac troponin I with a photonic crystal biosensor |
| Q55431760 | MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy. |
| Q92643141 | Machine Learning to Predict the Likelihood of Acute Myocardial Infarction |
| Q37328708 | Macrophage migration inhibitory factor for the early prediction of infarct size. |
| Q58602811 | Magnetoresistive biosensors with on-chip pulsed excitation and magnetic correlated double sampling |
| Q38192517 | Making sense of high sensitivity troponin assays and their role in clinical care |
| Q57153075 | Management strategies for patients with low-risk chest pain in the emergency department |
| Q48178212 | Marker Games: Seeking Better Biomarkers? |
| Q37040319 | Measurement of cardiac troponins to detect myocardial infarction using high-sensitivity assays: South African guidelines. |
| Q47140141 | MiRroring the Multiple Potentials of MicroRNAs in Acute Myocardial Infarction |
| Q27000432 | MicroRNAs as biomarkers for myocardial infarction |
| Q35860686 | MicroRNAs in patients on chronic hemodialysis (MINOS study). |
| Q45370584 | Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease |
| Q35684928 | Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin |
| Q98175258 | Monitoring Canine Myocardial Infarction Formation and Recovery via Transthoracic Cardiac Strain Imaging |
| Q36060247 | Multi-marker strategy of natriuretic peptide with either conventional or high-sensitivity troponin-T for acute coronary syndrome diagnosis in emergency department patients with chest pain: from the "Rule Out Myocardial Infarction using Computer Assi |
| Q48165741 | Multibiomarker analysis in patients with acute myocardial infarction |
| Q92152497 | Multicentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registry |
| Q36205883 | Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study |
| Q36070049 | Multiple biomarkers for risk prediction in chronic heart failure. |
| Q48006310 | Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study |
| Q36438801 | Myocardial ischaemia after hip and knee arthroplasty: incidence and risk factors |
| Q30426457 | Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study |
| Q89476642 | Myoglobin for Detection of High-Risk Patients with Acute Myocarditis |
| Q35692595 | No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome |
| Q33773136 | Non-commutability of results of highly sensitive troponin I and T immunoassays. |
| Q51055801 | Normal presenting levels of high-sensitivity troponin and myocardial infarction. |
| Q85212688 | Not a high‐sensitivity troponin T assay |
| Q38714511 | Novel Biomarkers of Subclinical Cardiac Dysfunction in the General Population |
| Q38613760 | Novel biomarkers for cardiovascular risk assessment: current status and future directions |
| Q38841682 | Novel biomarkers predicting cardiac function after acute myocardial infarction |
| Q50895062 | Novel high-sensitivity troponin assay requires higher cut-off value to separate acute myocardial infarction from non-acute myocardial infarction in a high-risk population. |
| Q39562368 | Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia |
| Q45103538 | Obstructive sleep apnea and acute myocardial infarction severity: ischemic preconditioning? |
| Q30487537 | Open access integrated therapeutic and diagnostic platforms for personalized cardiovascular medicine |
| Q35684923 | Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction |
| Q50864248 | Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial b |
| Q40272818 | Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database. |
| Q50333529 | Outcomes of non-invasive diagnostic modalities for the detection of coronary artery disease: network meta-analysis of diagnostic randomised controlled trials. |
| Q45066433 | Outliers affecting cardiac troponin I measurement: comparison of a new high sensitivity assay with a contemporary assay on the Abbott ARCHITECT analyser |
| Q55329170 | Pacemaker Implantation Associated Myocardial Micro-Damage: A Randomised Comparison between Active and Passive Fixation Leads. |
| Q46432572 | Performance of a sensitive troponin assay in the early diagnosis of acute myocardial infarction in the emergency department |
| Q38374170 | Performance of highly sensitive cardiac troponin T assay to detect ischaemia at PET-CT in low-risk patients with acute coronary syndrome: a prospective observational study |
| Q34280264 | Performance of the high-sensitivity troponin assay in diagnosing acute myocardial infarction: systematic review and meta-analysis |
| Q38138969 | Perspectives on the value of biomarkers in acute cardiac care and implications for strategic management |
| Q37240620 | Plasma Macrophage Migration Inhibitor Factor Is Elevated in Response to Myocardial Ischemia |
| Q34461130 | Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia |
| Q30374876 | Point-of-Care Technologies for the Advancement of Precision Medicine in Heart, Lung, Blood, and Sleep Disorders. |
| Q30357499 | Point-of-care diagnostics for niche applications. |
| Q93196470 | Post-exercise high-sensitivity troponin T levels in patients with suspected unstable angina |
| Q35884629 | Predictive role of high sensitivity troponin T within four hours from presentation of acute coronary syndrome in elderly patients |
| Q87888508 | Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction |
| Q48488258 | Predictive value of the heart-type fatty acid-binding protein and the Pulmonary Embolism Severity Index in patients with acute pulmonary embolism in the emergency department |
| Q48575848 | Predictive value of the novel risk score BETTER (BiomarkErs and compuTed Tomography scorE on Risk stratification) for patients with unstable angina |
| Q100525984 | Preoperative cardiac troponin below the 99th-percentile upper reference limit and 30-day mortality after noncardiac surgery |
| Q86476754 | Preserved prognostic value of preinterventional troponin T levels despite successful TAVI in patients with severe aortic stenosis |
| Q88869138 | Prevalence and outcome of patients referred for chest pain with high-sensitivity troponin elevation and no diagnosis at discharge |
| Q48693596 | Prevalence, characteristics and outcome of non-cardiac chest pain and elevated copeptin levels |
| Q55278810 | Prognostic implications of high-sensitivity cardiac troponin T assay in a real-world population with non-ST-elevation acute coronary syndrome☆. |
| Q91894396 | Prognostic implications of statin intolerance in stable coronary artery disease patients with different levels of high-sensitive troponin |
| Q58597439 | Prognostic significance and dynamic change of plasma macrophage migration inhibitory factor in patients with acute ST-elevation myocardial infarction |
| Q38259338 | Prognostic significance of elevated troponin in non-cardiac hospitalized patients: a systematic review and meta-analysis |
| Q35185710 | Prognostic utility of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) |
| Q92086257 | Prognostic value of elevated cardiac troponin I in patients with intracerebral hemorrhage |
| Q41243537 | Prognostic value of elevated high-sensitivity cardiac troponin T levels in a low risk outpatient population with cardiovascular disease |
| Q30876324 | Prognostic value of high-sensitivity troponin T levels in patients with ventricular arrhythmias and out-of-hospital cardiac arrest: data from the prospective FINNRESUSCI study |
| Q84853457 | Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis |
| Q49707707 | Prohormones in the Early Diagnosis of Cardiac Syncope |
| Q97092567 | Prospective comparative evaluation of the European Society of Cardiology (ESC) 1-hour and a 2-hour rapid diagnostic algorithm for myocardial infarction using high-sensitivity troponin-T |
| Q35011792 | Prospective external validation of an accelerated (2-h) acute coronary syndrome rule-out process using a contemporary troponin assay |
| Q35619706 | Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay. |
| Q37798014 | Proteomic biomarkers for diagnosis in acute myocardial infarction. |
| Q39050547 | Proteomics Research in Cardiovascular Medicine and Biomarker Discovery |
| Q36836327 | Providing Rapid Out of Hospital Acute Cardiovascular Treatment 4 (PROACT-4). |
| Q57044275 | Randomised controlled trial of the Limit of Detection of Troponin and ECG Discharge (LoDED) strategy versus usual care in adult patients with chest pain attending the emergency department: study protocol |
| Q35626702 | Recent advances in the diagnosis and treatment of acute myocardial infarction |
| Q34068784 | Recent advances in the management of chronic stable angina I: Approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities |
| Q37443166 | Recently published papers: Novel therapies in chronic obstructive pulmonary disease, cardiac chemicals and intensive care outcomes |
| Q58314269 | Recommendations for the use of cardiac troponin measurement in acute cardiac care |
| Q40141753 | Reducing short-stay hospital admissions by ruling out non-ST elevation myocardial infarction and estimating coronary artery disease likelihood on an emergency department observation ward |
| Q51366879 | Release kinetics of high-sensitivity cardiac troponins I and T and troponin T upstream open reading frame peptide (TnTuORF) in clinically induced acute myocardial infarction |
| Q56547325 | Retracted article: Concomitant measurement of copeptin and high-sensitivity troponin for fast and reliable rule out of acute myocardial infarction |
| Q92133268 | Revisiting the Biological Variability of Cardiac Troponin: Implications for Clinical Practice |
| Q36649949 | Rise of serum troponin levels following uncomplicated elective percutaneous coronary interventions in patients without clinical and procedural signs suggestive of myocardial necrosis |
| Q50633369 | Risk classification of highly sensitive troponin I predict presence of vulnerable plaque assessed by dual source coronary computed tomography angiography. |
| Q55397215 | Risk prediction in stable cardiovascular disease using a high-sensitivity cardiac troponin T single biomarker strategy compared to the ESC-SCORE. |
| Q58760095 | Risk stratification and role for additional diagnostic testing in patients with acute chest pain and normal high-sensitivity cardiac troponin levels |
| Q39680299 | Risk stratification in acute coronary syndromes |
| Q26769732 | Risk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgment |
| Q46738236 | Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide |
| Q36626934 | Roadmap for biomarkers of cancer therapy cardiotoxicity |
| Q38201763 | Role of MIF in myocardial ischaemia and infarction: insight from recent clinical and experimental findings |
| Q91749731 | Routine creatine kinase testing does not provide clinical utility in the emergency department for diagnosis of acute coronary syndromes |
| Q35130613 | Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study |
| Q51522487 | Sensitive cardiac troponin in the diagnosis and risk stratification of acute heart failure. |
| Q35234629 | Sensitive troponin assays in patients with suspected acute coronary syndrome: Results from the multicenter rule out myocardial infarction using computer assisted tomography II trial |
| Q34451008 | Sensitive troponins--which suits better for hemodialysis patients? Associated factors and prediction of mortality |
| Q96641742 | Sensitivity and Specificity of Bedside Qualitative Troponin I Test Kit as Compared with the Standardized Quantitative Lab Test for Troponin I |
| Q36837596 | Serial High-Sensitivity Troponin T in Post-Primary Angioplasty Exercise Test |
| Q45278231 | Serial high-sensitivity troponin measurements for the rapid exclusion of acute myocardial infarction in low-risk patients |
| Q35735050 | Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease |
| Q42215285 | Serum Metabolomics Profiling to Identify Biomarkers for Unstable Angina |
| Q36873646 | Serum cardiac troponin I concentrations in dogs with systemic inflammatory response syndrome |
| Q37141019 | Serum extracellular vesicle protein levels are associated with acute coronary syndrome |
| Q99564847 | Sex-specific effects of implementing a high-sensitivity troponin I assay in patients with suspected acute coronary syndrome: results from SWEDEHEART registry |
| Q48033043 | Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally? |
| Q47416926 | Signal self-enhancement by coordinated assembly of gold nanoparticles enables accurate one-step-immunoassays |
| Q37073532 | Single resting hsTnT level predicts abnormal myocardial stress test in acute chest pain patients with normal initial standard troponin |
| Q95651532 | StatinImplications of the complex biology and micro-environment of cardiac sarcomeres in the use of high affinity troponin antibodies as serum biomarkers for cardiac disorders |
| Q38551776 | Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers |
| Q60143984 | Stratified Reporting of High Sensitivity Troponin I Assay Is Associated With Suboptimal Management of Patients With Acute Coronary Syndrome and Intermediate Troponin Elevation |
| Q37793336 | Stress testing before discharge is not required for patients with low and intermediate risk of acute coronary syndrome after emergency department short stay assessment |
| Q34610511 | Subclinical myocardial necrosis and cardiovascular risk in stable patients undergoing elective cardiac evaluation |
| Q34172185 | Surviving the infarct: A profile of cardiac myosin binding protein-C pathogenicity, diagnostic utility, and proteomics in the ischemic myocardium. |
| Q38076348 | Targeting therapy to the fibrin-mediated pathophysiology of acute coronary syndrome |
| Q53306185 | Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. |
| Q34604478 | Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association |
| Q37710758 | The 2017 International Joint Working Group recommendations of the Indian College of Cardiology, the Academic College of Emergency Experts, and INDUSEM on the management of low-risk chest pain in emergency departments across India. |
| Q41565126 | The Diagnostic Value of Global Longitudinal Strain (GLS) on Myocardial Infarction Size by Echocardiography: A Systematic Review and Meta-analysis |
| Q58696046 | The Effects of Geography on Outcomes of Routine Early Versus Selective Late Revascularization Strategy in the Treatment of Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Transatlantic Randomized Controlled Tria |
| Q56960609 | The HEART score with high-sensitive troponin T at presentation: ruling out patients with chest pain in the emergency room |
| Q41650939 | The Manchester Acute Coronary Syndromes (MACS) decision rule: validation with a new automated assay for heart-type fatty acid binding protein. |
| Q39017422 | The Prognostic Value of Heart Type Fatty Acid Binding Protein in Patients with Suspected Acute Coronary Syndrome: A Systematic Review |
| Q50055934 | The Usefulness and Limitations of Point-of-care Cardiac Troponin Measurement in the Emergency Department. |
| Q37613422 | The cardiotoxicity of cetuximab as single therapy in Chinese chemotherapy-refractory metastatic colorectal cancer patients |
| Q36698261 | The development and application of a high-sensitivity immunoassay for cardiac myosin-binding protein C |
| Q53131264 | The diagnostic utility of CT coronary angiography in patients with acute chest pain. |
| Q33163075 | The emperor's new clothes: hypersensitivity of the new cardiac isoenzymes |
| Q92624983 | The feasibility of the 1-h high-sensitivity cardiac troponin T algorithm to rule-in and rule-out acute myocardial infarction in Thai emergency patients: an observational study |
| Q89912295 | The impact of an acute chest pain pathway on the investigation and management of cardiac chest pain |
| Q42943900 | The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes |
| Q38788956 | The potential of optimizing prehospital triage of patients with suspected acute myocardial infarction using high-sensitivity cardiac troponin T and copeptin |
| Q36084618 | The prognostic value of high sensitivity troponin T 7 weeks after an acute coronary syndrome |
| Q92936133 | The rise and fall of aspirin in the primary prevention of cardiovascular disease |
| Q37129419 | The role of cardiac biomarkers in the diagnosis and management of patients presenting with suspected acute coronary syndrome |
| Q34134378 | The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department |
| Q100418466 | The role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and Cardio-Oncology Council of the European Society of Cardiology |
| Q35308787 | The state of point-of-care testing: a European perspective |
| Q34139055 | The utility of troponin measurement to detect myocardial infarction: review of the current findings. |
| Q38049324 | Towards appreciating appropriate clinical responses to highly sensitive cardiac troponin assays |
| Q42373681 | Trends in Use of Biomarker Protocols for the Evaluation of Possible Myocardial Infarction |
| Q39655768 | Troponin I as a prognostic marker of cardiac events in asymptomatic hemodialysis patients using a sensitive troponin I assay |
| Q36126885 | Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients |
| Q36527607 | Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality |
| Q36233107 | Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes |
| Q28073071 | Troponin assay use in the emergency department for management of patients with potential acute coronary syndrome: current use and future directions |
| Q89147325 | Troponin assays: developing indications |
| Q35196125 | Troponin elevation in acute ischemic stroke (TRELAS)--protocol of a prospective observational trial |
| Q24630238 | Troponin elevation in conditions other than acute coronary syndromes |
| Q37822227 | Troponin elevation in coronary vs. non-coronary disease |
| Q45880675 | Troponin elevations only detected with a high-sensitivity assay: clinical correlations and prognostic significance |
| Q35701327 | Troponin in diabetic patients with and without chronic coronary artery disease |
| Q35550348 | Troponin-keep up or be left behind |
| Q38499448 | Troponins and other biomarkers in the early diagnosis of acute myocardial infarction |
| Q53711932 | Troponins in equipoise. |
| Q64097090 | True 99th centile of high sensitivity cardiac troponin for hospital patients: prospective, observational cohort study |
| Q38556611 | Type 2 myocardial infarction: the chimaera of cardiology? |
| Q40171388 | Ultra-sensitive troponin I is an independent predictor of incident coronary heart disease in the general population |
| Q45394375 | Uric acid for diagnosis and risk stratification in suspected myocardial infarction |
| Q58604607 | Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia: A Cohort Study |
| Q30402943 | Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs) to Monitor Compound Effects on Cardiac Myocyte Signaling Pathways |
| Q37716115 | Use of cardiac biomarker testing in the emergency department |
| Q38137842 | Use of high-sensitivity troponin assays predicts mortality in patients with normal conventional troponin assays on admission-insights from a meta-analysis. |
| Q41226728 | Usefulness of high-sensitivity troponin I for the monitoring of subclinical acute cellular rejection after cardiac transplantation |
| Q39018351 | Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy |
| Q39268332 | Using expert elicitation to estimate the potential impact of improved diagnostic performance of laboratory tests: a case study on rapid discharge of suspected non-ST elevation myocardial infarction patients. |
| Q104486548 | Utilization of silicon nanowire field-effect transistors for the detection of a cardiac biomarker, cardiac troponin I and their applications involving animal models |
| Q47772721 | Validation of NICE diagnostic guidance for rule out of myocardial infarction using high-sensitivity troponin tests |
| Q36982063 | Variation in and prognostic importance of troponin T measured using a high-sensitivity assay in clinically stable haemodialysis patients |
| Q92941656 | Wearable Real-Time Heart Attack Detection and Warning System to Reduce Road Accidents |
| Q82300603 | [BNP in HIV-infected patients] |
| Q83474563 | [Cardiac biomarkers in the critically ill] |
| Q88991681 | [Cardiac causes of chest pain] |
| Q84107265 | [Diagnostics of acute myocardial infarction in elderly patients] |
| Q87499438 | [Essential cardiac biomarkers in myocardial infarction and heart failure] |
| Q87370707 | [Timing of invasive treatment in NSTEMI: as fast as in STEMI?] |
| Q52860430 | [Troponin elevation in ischemic stroke patients]. |
| Q36278859 | hs-Troponin I Followed by CT Angiography Improves Acute Coronary Syndrome Risk Stratification Accuracy and Work-Up in Acute Chest Pain Patients: Results From ROMICAT II Trial |
| Q22242895 | ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el |
Search more.